




Figure S1.  FRIPS and CAD spectra of positively charged bradykinin. 
Figure S2.  FRIPS and CAD spectra of positively charged anxiety peptide. 
Figure S3.  FRIPS and CAD spectra of negatively charged met-enkephalin. 
Scheme S1.  Possible mechanism for FRIPS fragmentation. 
The peptide fragment ion nomenclature used in the communication and supporting 
information is that of Biemann, from “Appendix 5.  Nomenclature for Peptide Fragment 






















Figure S1.  (a) Spectrum resulting from CAD of doubly protonated A, where the peptide 
is bradykinin.  The “m” refers to a peptide fragment with a Vazo 68 radical fragment (-
COCH2CH2CH(CH3)CN) attached to the N terminus; “M” refers to a peptide fragment 
with –COCH3 attached to the N terminus.  (b)  Spectrum resulting from CAD of doubly 




Figure S2.  (a) Spectrum resulting from CAD of doubly protonated A, where the peptide 
is anxiety peptide, QATVGDVNTDRPGLLDLK. The “m” refers to a peptide fragment 
with a Vazo 68 radical fragment (-COCH2CH2CH(CH3)CN) attached to the N terminus; 
“M” refers to a peptide fragment with –COCH3 attached to the N terminus.  (b)  
Spectrum resulting from CAD of doubly protonated unmodified anxiety peptide.  Arrows 




Figure S1.  (a) Spectrum resulting from CAD of B, where the peptide is met-enkephalin, 
YGGFM.  (b)  Spectrum resulting from CAD of singly negatively charged unmodified 



























































































Scheme S1.  Possible FRIPS mechanisms, explaining the observation of c, z, x, and a 
type fragments.   
